Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1305)
Stablecoin Development Corp (SDEV)
Kazley Michael John — Director
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Stablecoin Development Corp (SDEV)
Framework Ventures IV L.P. — 10% Owner
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Stablecoin Development Corp (SDEV)
R01 Fund LP — 10% Owner
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
100,000
Price
$17.37
Total Value
$1.74M
Shares Held After
1,412,058
% of Holdings
6.6%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
60,400
Price
$160.17
Total Value
$9.67M
Shares Held After
158,222
% of Holdings
27.6%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
6,657
Price
$16.39
Total Value
$109.08K
Shares Held After
232,457
% of Holdings
2.8%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
3,328
Price
$16.38
Total Value
$54.53K
Shares Held After
239,114
% of Holdings
1.4%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
3,329
Price
$16.39
Total Value
$54.56K
Shares Held After
242,442
% of Holdings
1.4%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
272,322
Price
$45.02
Total Value
$12.26M
Shares Held After
7,388,902
% of Holdings
3.6%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
9,086
Price
$45.02
Total Value
$409.05K
Shares Held After
245,728
% of Holdings
3.6%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
5,538
Price
$60.71
Total Value
$336.21K
Shares Held After
15,437
% of Holdings
26.4%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
96,000
Price
$0.04
Total Value
$4.32K
Shares Held After
93,389,560
% of Holdings
0.1%
CytomX Therapeutics, Inc. (CTMX)
Ogden Christopher — Chief Financial Officer
Shares
1,624
Price
$3.05
Total Value
$4.95K
Shares Held After
295,324
% of Holdings
0.5%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
100
Price
$31.46
Total Value
$3.15K
Shares Held After
135,209
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,191
Price
$31.05
Total Value
$68.03K
Shares Held After
135,309
% of Holdings
1.6%
Acumen Pharmaceuticals, Inc. (ABOS)
Porter Derrell — Director
Shares
6,460
Price
$2.35
Total Value
$15.15K
Shares Held After
48,300
% of Holdings
11.8%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
53,336
Price
$51.37
Total Value
$2.74M
Shares Held After
1,483,848
% of Holdings
3.5%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
59
Price
$27.94
Total Value
$1.65K
Shares Held After
81,600
% of Holdings
0.1%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
224
Price
$27.12
Total Value
$6.08K
Shares Held After
81,659
% of Holdings
0.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
4,062
Price
$450.00
Total Value
$1.83M
Shares Held After
16,953
% of Holdings
19.3%
Immunome Inc. (IMNM)
Rosett Max — Chief Financial Officer
Shares
60,000
Price
$18.23
Total Value
$1.09M
Shares Held After
54,037
% of Holdings
52.6%
Ocugen, Inc. (OCGN)
Johnson-Greene Treerita Essalima — Chief Financial Officer
Shares
21,000
Price
$1.23
Total Value
$25.83K
Shares Held After
521,000
% of Holdings
4.0%
Clearmind Medicine Inc. (CMND)
HRT FINANCIAL LP — 10% Owner
Shares
3,183
Price
$3.32
Total Value
$10.57K
Shares Held After
103,492
% of Holdings
3.0%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.19
Total Value
$10.19K
Shares Held After
17,592
% of Holdings
5.7%
Jazz Pharmaceuticals plc (JAZZ)
Smith Mark Douglas — Director
Shares
1,157
Price
$230.55
Total Value
$266.75K
Shares Held After
9,680
% of Holdings
10.7%
uniQure N.V. (QURE)
Potts Jeannette — Chief Legal Officer
Shares
5,237
Price
$27.67
Total Value
$144.91K
Shares Held After
133,246
% of Holdings
3.8%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
1,503
Price
$67.14
Total Value
$100.92K
Shares Held After
6,589
% of Holdings
18.6%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
88,737
Price
$66.62
Total Value
$5.91M
Shares Held After
8,092
% of Holdings
91.6%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
10,000
Price
$27.85
Total Value
$278.50K
Shares Held After
43,254
% of Holdings
18.8%
Tarsus Pharmaceuticals, Inc. (TARS)
Goodrich Katherine — Director
Shares
2,954
Price
$62.08
Total Value
$183.38K
Shares Held After
2,233
% of Holdings
57.0%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
1,928
Price
$62.94
Total Value
$121.35K
Shares Held After
106,786
% of Holdings
1.8%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
10,572
Price
$61.97
Total Value
$655.15K
Shares Held After
108,714
% of Holdings
8.9%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
2
Price
$82.45
Total Value
$164.90
Shares Held After
16,130
% of Holdings
0.0%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
19,483
Price
$81.81
Total Value
$1.59M
Shares Held After
16,132
% of Holdings
54.7%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
11,081
Price
$80.94
Total Value
$896.92K
Shares Held After
35,615
% of Holdings
23.7%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
9,434
Price
$80.02
Total Value
$754.92K
Shares Held After
46,696
% of Holdings
16.8%
Xencor Inc (XNCR)
RANIERI RICHARD J — Director
Shares
5,474
Price
$12.31
Total Value
$67.38K
Shares Held After
13,709
% of Holdings
28.5%
Xencor Inc (XNCR)
Montgomery Alan Bruce — Director
Shares
5,064
Price
$12.31
Total Value
$62.34K
Shares Held After
15,547
% of Holdings
24.6%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,666
Price
$5.67
Total Value
$236.35K
Shares Held After
1,699,200
% of Holdings
2.4%
Xencor Inc (XNCR)
GUSTAFSON KURT A — Director
Shares
5,474
Price
$12.31
Total Value
$67.38K
Shares Held After
14,709
% of Holdings
27.1%
Xencor Inc (XNCR)
GORMAN KEVIN CHARLES — Director
Shares
7,527
Price
$12.31
Total Value
$92.66K
Shares Held After
11,378
% of Holdings
39.8%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
8,554
Price
$0.39
Total Value
$3.34K
Shares Held After
341,353
% of Holdings
2.4%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
120,216
Price
$0.39
Total Value
$46.88K
Shares Held After
4,797,350
% of Holdings
2.4%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
15,414
Price
$8.99
Total Value
$138.57K
Shares Held After
16,638,150
% of Holdings
0.1%
IONIS PHARMACEUTICALS INC (IONS)
BERTHELSEN SPENCER R — Director
Shares
8,000
Price
$73.49
Total Value
$587.92K
Shares Held After
156,013
% of Holdings
4.9%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
1,310
Price
$60.12
Total Value
$78.76K
Shares Held After
0
% of Holdings
100.0%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
654
Price
$60.12
Total Value
$39.32K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$553.47
Total Value
$509.20K
Shares Held After
40,513
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$552.59
Total Value
$419.97K
Shares Held After
41,433
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,180
Price
$551.57
Total Value
$650.85K
Shares Held After
42,193
% of Holdings
2.7%
Showing 801–850 of 1305 transactions (page 17 of 27)